Condensed Statements of Changes in Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022		41,025,062
Beginning balance at Dec. 31, 2022	$ 188,775	$ 4	$ 359,949	$ (170,427)	$ (751)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized gain (loss) on marketable securities	227				227
Stock-based compensation	1,390		1,390
Net loss	(11,307)			(11,307)
Ending balance (in shares) at Mar. 31, 2023		41,025,062
Ending balance at Mar. 31, 2023	$ 179,085	$ 4	361,339	(181,734)	(524)
Beginning balance (in shares) at Dec. 31, 2023	57,910,461	57,910,461
Beginning balance at Dec. 31, 2023	$ 266,973	$ 6	489,453	(222,798)	312
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for cash, net of issuance costs of $87 (in shares)		2,068,246
Issuance of common stock for cash, net of issuance costs of $87	7,938		7,938
Issuance of common stock for restricted stock units, net of shares withheld for taxes (in shares)		101,071
Issuance of common stock for restricted stock units, net of shares withheld for taxes	(32)		(32)
Unrealized gain (loss) on marketable securities	(456)				(456)
Stock-based compensation	2,484		2,484
Net loss	$ (14,873)			(14,873)
Ending balance (in shares) at Mar. 31, 2024	60,079,778	60,079,778
Ending balance at Mar. 31, 2024	$ 262,034	$ 6	$ 499,843	$ (237,671)	$ (144)